CD274 and non-small cell lung carcinoma: In the study of Routy et al., the antibiotic intervention was explored and believed to largely perturb the anti-PD-L1 therapeutic efficacy caused by gut dysbiosis, contributing to the subsequential relapse and shortened survival rate in NSCLC and RCC patients (22).